USANA Health Sciences, Inc. (USNA) Shares Sold by TIAA CREF Investment Management LLC

TIAA CREF Investment Management LLC decreased its stake in shares of USANA Health Sciences, Inc. (NYSE:USNA) by 2.6% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 91,914 shares of the company’s stock after selling 2,478 shares during the period. TIAA CREF Investment Management LLC’s holdings in USANA Health Sciences were worth $5,294,000 as of its most recent SEC filing.

A number of other institutional investors also recently bought and sold shares of USNA. Dimensional Fund Advisors LP raised its position in USANA Health Sciences by 103.8% in the fourth quarter. Dimensional Fund Advisors LP now owns 685,877 shares of the company’s stock valued at $41,976,000 after buying an additional 349,380 shares during the period. Teachers Advisors LLC raised its position in USANA Health Sciences by 137.7% in the fourth quarter. Teachers Advisors LLC now owns 217,677 shares of the company’s stock valued at $13,322,000 after buying an additional 126,090 shares during the period. Norges Bank acquired a new position in USANA Health Sciences during the fourth quarter valued at approximately $6,855,000. FMR LLC raised its position in USANA Health Sciences by 7.1% in the first quarter. FMR LLC now owns 1,538,110 shares of the company’s stock valued at $88,595,000 after buying an additional 102,086 shares during the period. Finally, State Street Corp raised its position in USANA Health Sciences by 104.3% in the fourth quarter. State Street Corp now owns 190,838 shares of the company’s stock valued at $11,676,000 after buying an additional 97,430 shares during the period. 44.21% of the stock is owned by institutional investors.

USANA Health Sciences, Inc. (NYSE:USNA) opened at 63.90 on Thursday. The firm’s 50-day moving average is $64.33 and its 200 day moving average is $60.93. The company has a market cap of $1.57 billion, a price-to-earnings ratio of 16.13 and a beta of 1.13. USANA Health Sciences, Inc. has a 52-week low of $52.55 and a 52-week high of $75.00.

USANA Health Sciences (NYSE:USNA) last announced its quarterly earnings results on Tuesday, May 2nd. The company reported $0.91 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.92 by $0.01. The business had revenue of $255.32 million during the quarter. USANA Health Sciences had a net margin of 9.71% and a return on equity of 31.84%. On average, equities research analysts predict that USANA Health Sciences, Inc. will post $3.95 EPS for the current fiscal year.

WARNING: This piece was reported by Sports Perspectives and is the sole property of of Sports Perspectives. If you are accessing this piece on another publication, it was copied illegally and reposted in violation of US & international copyright legislation. The original version of this piece can be read at https://sportsperspectives.com/2017/07/20/usana-health-sciences-inc-usna-shares-sold-by-tiaa-cref-investment-management-llc.html.

Several equities analysts have commented on the stock. BidaskClub lowered shares of USANA Health Sciences from a “hold” rating to a “sell” rating in a research report on Sunday. Pivotal Research upgraded shares of USANA Health Sciences from a “hold” rating to a “buy” rating and increased their price objective for the company from $55.00 to $75.00 in a research report on Wednesday, May 3rd. Finally, Zacks Investment Research upgraded shares of USANA Health Sciences from a “sell” rating to a “hold” rating in a research report on Wednesday, April 12th.

In other USANA Health Sciences news, Director Gilbert A. Fuller sold 4,884 shares of the firm’s stock in a transaction on Thursday, May 11th. The stock was sold at an average price of $64.38, for a total value of $314,431.92. Following the completion of the sale, the director now owns 4,884 shares of the company’s stock, valued at $314,431.92. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, insider Paul A. Jones sold 9,851 shares of the firm’s stock in a transaction on Thursday, June 1st. The shares were sold at an average price of $64.50, for a total value of $635,389.50. Following the completion of the sale, the insider now directly owns 6,020 shares of the company’s stock, valued at approximately $388,290. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 134,735 shares of company stock valued at $8,371,021. Corporate insiders own 53.20% of the company’s stock.

About USANA Health Sciences

USANA Health Sciences, Inc develops and manufactures science-based nutritional and personal care products. The Company operates as a direct selling company in two geographic regions: Americas and Europe, and Asia Pacific, which includes three sub-regions: Southeast Asia Pacific, Greater China and North Asia.

Want to see what other hedge funds are holding USNA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for USANA Health Sciences, Inc. (NYSE:USNA).

Institutional Ownership by Quarter for USANA Health Sciences (NYSE:USNA)

Receive News & Ratings for USANA Health Sciences Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply